Breaking News

Looming abortion pill ban could undermine drug approval system; it’s easy to buy altered ‘weed’ even where marijuana's illegal

February 23, 2023
Molly Ferguson for STAT

'A slippery slope': A looming nationwide abortion pill ban could undermine the entire drug approval system

If an attempted ban on the abortion pill prevails in court, it could undermine the FDA and the country's infrastructure for evaluating drugs.

By Eric Boodman


STAT+ | The FDA plans to regulate far more AI tools as devices. The industry won't go down without a fight

The FDA is taking a tougher stance on AI tools in medicine. The health tech industry is pushing back, arguing regulators are overstepping.

By Lizzy Lawrence


STAT+ | Its founder hopes to reverse aging, but first Tally Health wants to test how fast your biological clock ticks

A scientist whose test was licensed by a competing company said "it's still really early days" for estimating biological age.

By Megan Molteni



Signs for "legal THC" are posted outside a business in Topeka, Kan.
Nicholas Florko/STAT

How I found 'Trips Ahoy' and 'Blackberry Diesel' 'weed' vapes in a state where marijuana is very much illegal

Cannabis varieties like Delta 10 THC, HHC and THC-O raise legal, medical questions in Kansas, where possession of marijuana is still a crime.

By Nicholas Florko


STAT+ | DaVita faces another probe over ties to kidney care charity

The D.C. attorney general is investigating the dialysis provider DaVita and its ties to the nonprofit American Kidney Fund.

By Bob Herman


Opinion: The Supreme Court doesn't belong in your medicine cabinet

Health care leaders need to speak out about the repercussions of taking away medical sovereignty from 40 million women.

By Paul J. Hastings


Adobe

Opinion: 'They don't need your permission.' When childbirth feels like rape

The principles of trauma-informed care should guide prenatal care, childbirth, and postpartum care for all.

By Lisa Rab


Listen: Vertex vs. insurers, Moderna's future, & biotech's long winter

STAT's Ed Silverman joins us to explain how an escalating fight between Vertex and insurers has left patients caught in the middle.

By Damian Garde and Meg Tirrell and Adam Feuerstein


More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

Enjoying Daily Recap? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2023, All Rights Reserved.

No comments